Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 431,469 | 551,272 | 547,898 | 374,710 | 247,675 |
| Receivables | 120,355 | 117,512 | 65,939 | 83,534 | 121,821 |
| Inventories | 51,409 | 51,557 | 56,246 | 47,781 | 47,129 |
| Other current assets | 0 | 0 | 0 | 125,034 | 0 |
| TOTAL | $619,135 | $740,039 | $687,478 | $644,491 | $425,543 |
| Non-Current Assets | |||||
| PPE Net | 47,702 | 46,332 | 108,322 | 104,751 | 105,133 |
| Intangibles | 518,940 | 270,337 | 273,991 | 277,882 | 396,891 |
| Other Non-Current Assets | 857,453 | 861,568 | 824,892 | 574,123 | 424,201 |
| TOTAL | $1,424,095 | $1,178,237 | $1,207,205 | $956,756 | $926,225 |
| Total Assets | $2,043,230 | $1,918,276 | $1,894,683 | $1,601,247 | $1,351,768 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,440 | 6,000 | 6,000 | 6,000 | 6,000 |
| Accounts payable and accrued liabilities | 10,384 | 8,154 | 8,917 | 11,704 | 9,806 |
| Accrued Expenses | 32,411 | 34,574 | 31,422 | 24,794 | 28,973 |
| Other current liabilities | N/A | N/A | N/A | 11,487 | N/A |
| TOTAL | $86,675 | $93,777 | $114,352 | $164,773 | $165,252 |
| Non-Current Liabilities | |||||
| Long Term Debt | 524,499 | 524,591 | 525,584 | 526,583 | 527,593 |
| Deferred Revenues | 3,693 | 10,211 | 66,715 | 109,490 | 119,175 |
| Other Non-Current Liabilities | 697,756 | 683,266 | 667,592 | 435,770 | 332,309 |
| TOTAL | $1,302,253 | $1,279,138 | $1,326,715 | $1,103,333 | $976,760 |
| Total Liabilities | $1,388,928 | $1,372,915 | $1,441,067 | $1,268,106 | $1,142,012 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 255,207 | 255,159 | 257,698 | 257,660 | 257,660 |
| Common Shares | 2,552 | 2,552 | 2,576 | 2,576 | 2,576 |
| Retained earnings | 251,423 | 184,561 | 127,450 | 73,176 | 24,101 |
| Other shareholders' equity | 271,743 | 229,862 | 150,979 | 139,181 | 97,103 |
| TOTAL | $654,302 | $545,361 | $453,616 | $333,141 | $209,756 |
| Total Liabilities And Equity | $2,043,230 | $1,918,276 | $1,894,683 | $1,601,247 | $1,351,768 |